Contact
Please use this form to send email to PR contact of this press release:
Allogene Therapeutics Presents Preclinical Findings Supporting an Allogeneic DLL3 CAR for Small Cell Lung Cancer and Development of an Inducible TurboCARâ„¢ at the American Association for Cancer Research (AACR) Virtual 2020 Meeting
TO: